HBLRX Hartford Balanced Income R3 Forecast, Technical & Fundamental Analysis

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Johnson & Johnson (NYSE:JNJ), Philip Morris International (NYSE:PM), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), ConocoPhillips (NYSE:COP), EOG Resources (NYSE:EOG), MetLife (NYSE:MET).

The investment seeks to provide current income with growth of capital as a secondary objective. The fund targets an allocation of approximately 45% equity securities and 55% fixed income investments, with the allocation generally varying by no more than +/-5%. The equity portion of the fund invests primarily in common stocks with a history of above-average dividends or expectations of increasing dividends. It may invest up to 20% of the fixed income portion of the portfolio in domestic non-investment grade debt.

The average market capitalization across the Hartford Balanced Income R3 MF is 265.04B. The market cap for tickers in the group ranges from 54.19B to 814.59B. JPM holds the highest valuation in this group at 814.59B. The lowest valued company is MET at 54.19B.

The average weekly volume growth across all stocks in the Hartford Balanced Income R3 MF was 8%. For the same stocks of the MF, the average monthly volume growth was -13% and the average quarterly volume growth was -31%